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A B S T R A C T
Bluetongue virus (BTV) causes severe disease in domestic and wild ruminants, and has recently caused
several outbreaks in Europe. Current vaccines include live-attenuated and inactivated viruses; while
these are effective, there is risk of reversion to virulence by mutation or reassortment with wild type
viruses. Subunit or virus-like particle (VLP) vaccines are safer options: VLP vaccines produced in insect
cells by expression of the four BTV capsid proteins are protective against challenge; however, this is a
costly production method. We investigated production of BTV VLPs in plants via Agrobacterium-mediated
transient expression, an inexpensive production system very well suited to developing country use.
Leaves inﬁltrated with recombinant pEAQ-HT vectors separately encoding the four BTV-8 capsid proteins
produced more proteins than recombinant pTRA vectors. Plant expression using the pEAQ-HT vector
resulted in both BTV-8 core-like particles (CLPs) and VLPs; differentially controlling the concentration of
inﬁltrated bacteria signiﬁcantly inﬂuenced yield of the VLPs. In situ localisation of assembled particles
was investigated by using transmission electron microscopy (TEM) and it was shown that a mixed
population of core-like particles (CLPs, consisting of VP3 and VP7) and VLPs were present as
paracrystalline arrays in the cytoplasm of plant cells co-expressing all four capsid proteins.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Bluetongue virus (BTV) is the causative agent of Bluetongue
(BT) disease, an insect-borne, infectious but non-contagious
disease of both domesticated and wild ruminants. BTV is a
double-stranded RNA (dsRNA) virus that is the type species of the
genus Orbivirus in the family Reoviridae [29]. BTV was ﬁrst
discovered and reported on in South Africa as “malarial catarrhal
fever” in 1902 [16] and has since spread worldwide. At present,
26 serotypes of the virus have been described [19]. The virulence
and mortality rate of the different virus strains vary considerably,
depending on the species of animal being infected [9,14,20,41].
There has been a gradual movement of Bluetongue disease into
previously unaffected areas in northern Europe and an emergence
of several different BTV serotypes in the United States and
Northern Australia [3]. Bluetongue disease is now considered
endemic in northern Europe, probably as a result of climate change
leading to migration of viruliferous vectors from Africa, with the
most recent outbreak of BTV serotype 8 (BTV-8) occurring in
Northern Europe in August 2006 [38,40]. The virus was shown to* Corresponding author. Fax: +27 21 6502646.
E-mail addresses: alta.vanzyl@uct.ac.za (A.R. van Zyl), ann.meyers@uct.ac.za
(A.E. Meyers), ed.rybicki@uct.ac.za (E.P. Rybicki).
http://dx.doi.org/10.1016/j.btre.2015.12.001
2215-017X/ã 2015 The Authors. Published by Elsevier B.V. This is an open access article unhave originated in sub-Saharan Africa, although its route of entry
into the Netherlands is unclear. The disease is also common in
South Africa with occurrences correlating with high rainfall areas.
Virus-like particles (VLPs), which resemble the mature virus
particle in size and shape but lack any infectious viral genomic
material, are considered good immunogens as they are stable, elicit
a strong immune response and present the viral antigens in a
conformation that is more appropriate than subunit protein
vaccines [10,18,25].
BTV VLPs consisting only of the 4 immunogenic structural
proteins (virus capsid proteins) of BTV and containing no BTV RNA
have been produced in a variety of expression systems. BTV has
complex, multi-layered virions. The virus capsid proteins VP2 and
VP5 form an outer shell that is laid onto the foundation provided by
the assembly of VP3 and VP7, which together constitute the inner
shell [7]. When VP3 and VP7 are expressed in insect cells using a
baculovirus expression system, they form core-like particles (CLPs)
on their own. In the same expression system, VP2 and VP5 form
VLPs when co-expressed with VP3 and VP7 [7,28]. VLPs produced
in this manner have been shown to protect sheep against live virus
challenge [27]. However, despite their efﬁcacy, the cost of
producing VLPs in insect cells is traditionally fairly high, not very
scalable and there is the risk of contamination [22]. Thus,der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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desirable.
The transient expression of heterologous proteins in plants has
attracted much interest in recent years as a method for
recombinant protein production. There are many advantages of
using plants over other eukaryotic expression hosts including their
high yield of biomass, ease and affordability of scale-up and no risk
of contamination by human or animal pathogens [31,39]. A recent
study compared the production of four recombinant pharmaceu-
tical proteins using different expression systems. The study found
that when assuming all downstream processing costs are equal for
different expression platforms, the estimated production costs of
recombinant proteins in plants are lower than for other technolo-
gies [22]. Transient expression systems are ﬂexible and allow for
rapid expression of high concentrations of recombinant protein in
a matter of days [6]. There are many examples to date of
recombinant vaccine protein production in plants, including the
production of VLPs [2,35].
Thuenemann et al. [37] have demonstrated the successful
production of BTV-8 VLPs in Nicotiana benthamiana using the
Cowpea mosaic virus-based HyperTrans (CPMV-HT) and associat-
ed pEAQ transient expression system [32]. This involved the
inﬁltration of plants with 4 individual constructs encoding VP2,
VP3, VP5 and VP7. However, although particulate structures were
obtained, there was an over-representation of VP3 protein
expression, leading to the formation of considerable numbers of
subcore-like particles. To overcome this, the authors down-
regulated VP3 production by controlling expression of the
VP3 gene with the wild-type CPMV 50 UTR. Plants were inﬁltrated
with dual-expressing constructs encoding VP3 and VP7 together,
and VP2 and VP5 together, which resulted in a shift of particle
production biased to that of VLPs.
There are twenty-ﬁve different serotypes of BTV-25 circulating
in South Africa alone. The current vaccine used in South Africa
consists of 3 cocktails of 5 different live-attenuated BTV serotypes
[5]. For effective recombinant vaccines to accommodate such
requirements, the method for producing VLPs representing
different serotypes will have to be ﬂexible. It may be easier to
ﬁne-tune the production of plant-produced VLPs for vaccine
cocktails by making constructs encoding each VP representative of
each serotype and simply varying the ratios of inﬁltrated
constructs in order to direct serotype-speciﬁc VLP assembly.Table 1
Summary of plant expression vectors tested and constructs made.
Vector Restriction sites (50/30) Insert
pTRAc-HT NcoI/XhoI VP2 
VP3 
VP5 
VP7 
pTRAkc-AH NcoI/XhoI VP2 
VP3 
VP5 
VP7 
pTRAkc-rbcs1-cTP MluI/XhoI VP2 
VP3 
VP5 
VP7 
pEAQ-HT AgeI/XhoI VP2 
VP3 
VP5 
VP7 In order to increase expression levels and to facilitate easier
puriﬁcation of heterologous proteins from plants, expression
vectors that target all the co-expressed proteins to different
organelles within the plant cells can be used [21] to increase VLP
production.
In this study, co-expression of the four BTV-8 VPs in N.
benthamiana was compared by using the binary Agrobacterium
tumefaciens pTRA suite of vectors pTRAc-HT, pTRAkc-AH and
pTRAkc-rbcs1-cTP, which target recombinant protein to the
cytosol, apoplast and chloroplast respectively, in order to deter-
mine whether the expression yields could be improved by
targeting the recombinant proteins to different subcellular
compartments. In addition to the pTRA vectors, the VPs were also
co-expressed using pEAQ-HT which has the P19 silencing suppres-
sor sequence of TBSV incorporated into the T-DNA, enabling
expression of the gene of interest and the silencing suppressor
from a single plasmid [32] to compare which system best co-
expressed the four VPs. In addition, the effects of varying the
inﬁltration ratios of the four recombinant Agrobacterium cultures
containing VP recombinant constructs were analyzed as well as
variation of the density of inﬁltrated recombinant Agrobacterium
cells.
2. Material and methods
2.1. Constructs
The VP2,VP3, VP5 and VP7 gene sequences (GenBank accession
numbers: AM498052, AM498053, AM498056 and AM498057,
respectively) of BTV-8 were codon optimized for expression in N.
benthamiana and synthesized by GeneArt (Germany). The gene
sequences used in this study were the same as the genes used by
Thuenemann et al. [37].
The genes were cloned into 3 different pTRA binary vectors
(kindly provided by Dr Rainer Fischer, Fraunhofer Institute,
Aachen, Germany): pTRAc-HT, pTRAkc-AH and pTRAkc-rbcs1-
cTP. These are designed to target recombinant proteins to the
cytosol, apoplast and chloroplast, respectively [21]. The 50 and 30
termini of all 4 BTV-8 genes were modiﬁed by PCR to add
restriction sites to facilitate cloning into the pTRA vector suite.
Similarly, all 4 genes were modiﬁed and cloned into the pEAQ-HT
vector obtained from George Lomonossoff, John Innes Centre, UK
[32]. The constructs generated are shown in Table 1. Construct Subcellular target
pTRAc-HT VP2co Cytoplasm
pTRAc-HT VP3co
pTRAc-HT VP5co
pTRAc-HT VP7co
pTRAkc-AH VP2co Apoplast
pTRAkc-AH VP3co
pTRAkc-AH VP5co
pTRAkc-AH VP7co
pTRAkc-rbcs1-cTPVP2co Chloroplast
pTRAkc-rbcs1-cTPVP3co
pTRAkc-rbcs1-cTPVP5co
pTRAkc-rbcs1-cTPVP7co
pEAQ-HT VP2co Cytoplasm
pEAQ-HT VP3co
pEAQ-HT VP5co
pEAQ-HT VP7co
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Fifty to 100 ng of the pTRA and pEAQ-HT recombinant plasmids
was electroporated into A. tumefaciens GV3101::pMP90RK and A.
tumefaciens LBA4404, respectively as described by Maclean et al.
[21]. The pTRA and pEAQ-HT plasmid were transformed into
different Agrobacterium strains to allow for appropriate antibiotic
selection of recombinant clones [13]. Recombinant pTRA clones
were selected on Luria Bertani (LB) media plates at 27 C
containing 50 mg/mL carbenicillin, 30 mg/mL kanamycin and
50 mg/mL rifampicin. The pEAQ-HT clones were selected under
the same conditions except that carbenicillin was omitted from the
LB plates. Starter cultures of recombinant pTRA and pEAQ-HT
Agrobacterium, including A. tumefaciens LBA4404 (pBIN-NSs)
containing the NSs silencing-suppressor gene of tomato spotted
wilt virus (TSWV) [26], were supplemented with the relevant
antibiotics and grown in LB broth as previously described by
Maclean et al. [21]. Furthermore, to prevent clumping of
recombinant Agrobacterium LBA4404 cells, 2 mM magnesium
sulfate (MgSO4) was added to the medium. The starter cultures
were used to inoculate induction medium [21] with the addition of
the appropriate antibiotics, including 20 mM acetosyringone, and
grown overnight at 27 C with agitation. The cells were harvested
the following morning at 1000  g for 5 min and resuspended in
inﬁltration medium [21]. The cell suspensions were incubated at
22 C for 2 h with agitation to allow for expression of the vir genes
prior to inﬁltration. After incubation the cultures were diluted to
the required optical density in inﬁltration medium.
For each one of the expression vectors used, the relevant
recombinant Agrobacterium constructs carrying the capsid genes
were co-inﬁltrated into 4–6-week-old N. benthamiana leaves with
a blunt-ended syringe. Recombinant Agrobacterium pTRA strains
were co-inﬁltrated with pBIN-NSs. The pEAQ-HT recombinant
strains did not require co-inﬁltration with the silencing suppressor
as it has the P19 silencing suppressor integrated on the T-DNA of
the plasmid [32]. As a negative control the plants were inﬁltrated
with inﬁltration medium. The plants were grown at 22 C under
16 h/8 h light/dark cycles. Three leaf discs were harvested from
leaves 3, 4 and 5 from the top of the plant (1 leaf disc each, clipped
with the lid of a microcentrifuge tube) for each vector co-
expressing recombinant protein to form VLPs at 1, 3, 5 and 7 days
post inﬁltration (dpi).
2.3. Protein extraction and western blot analysis
The leaf discs were ground up in liquid nitrogen and
resuspended in 210 mL bicine buffer (50 mM bicine (pH 8.4),
20 mM sodium chloride (NaCl), 0.1% N-lauroyl-sarcosine (NLS),
1 mM DL-dithiothreitol (DTT) and 1 Complete Mini, EDTA-free
protease inhibitor cocktail (Roche)) by vortexing. Extracts were
clariﬁed by centrifugation at 15,000  g on a bench top centrifuge.
For western blot analysis, the crude plant extracts were
incubated at 90 C for 10 min in loading buffer [33]. The proteins
were separated on 8% SDS polyacrylamide gels where equal
amounts of total protein (120 mg as determined by spectrometry)
were loaded in each lane. After electrophoresis the proteins were
transferred onto nitrocellulose membranes using a Trans-blot1
SD semi-dry transfer cell (Bio-Rad). Membranes were probed
with a 1:2000 dilution of BTV-8 sheep serum [37] and
subsequently with a 1:10,000 dilution of anti-goat/sheep alkaline
phosphatase-conjugated secondary antibody (Sigma–Aldrich).
Detection was performed with 5-bromo-4-chloro-3-indoxyl-
phosphate (BCIP) and nitroblue tetrazolium (NBT) phosphatase
substrate (BCIP/NBT 1-component, KPL).2.4. Density gradient puriﬁcation of VLPs
Plants co-inﬁltrated with the 4 pEAQ-HT constructs were
harvested at 9 dpi and immediately cut up into ﬁne pieces and
homogenized in three volumes of ice cold bicine buffer (50 mM
bicine (pH 8.4), 20 mM sodium chloride (NaCl), and 1 Complete
Mini, EDTA-free protease inhibitor cocktail (Roche)) lacking NLS
and DTT. The homogenate was clariﬁed by centrifugation at
1000  g for 10 min after which the supernatant was ﬁltered
through four layers of MiraclothTM (Merck). The crude plant sap
was overlayed onto 5 mL of a 40% iodixanol (OptiprepTM, Sigma–
Aldrich) cushion prepared in 50 mM Tris–HCl, pH 8.4 and 20 mM
NaCl after which it was centrifuged for 2 h at 79,000  g in a SW
32 Ti rotor (Beckman). The 40% iodixanol cushion was collected
after centrifugation from the bottom of the tube and overlayed
onto 5 mL of a 20–60% step gradient (1 mL of each gradient in 10%
incrementing steps) and centrifuged as above. Fractions of 0.5 mL
were collected from the bottom of the tubes and analyzed by
western blotting (as described above) and TEM.
2.5. Transmission electron microscopy (TEM)
Copper grids (mesh size 200) were ﬂoated for 2 min on a
1:200 dilution of BTV-8 sheep serum and washed twice with
sterile water. Thereafter the grids were ﬂoated on a 1:10 dilution of
crude plant extract for 5 min and washed three times with sterile
water. The samples were negatively stained for 1 min with 2%
uranyl acetate. Fractionated samples from the density gradients
were treated similarly except they were not captured onto the
grids with anti-BTV-8 sheep serum. All grids were viewed using a
Technai G2 TEM.
2.6. In situ TEM of BTV-8 capsid proteins co-expressed in N.
benthamiana
Agrobacterium carrying the BTV-8 pEAQ-HT VP2co, pEAQ-HT
VP3co, pEAQ-HT VP5co and pEAQ-HT VP7co constructs were
cultured and combined (as described above) in a ratio of 1:1:2:1
(VP2:VP3:VP5:VP7) and syringe-inﬁltrated into the abaxial surfa-
ces of six-week-old N. benthamiana plants.
At 9 dpi 1 mm  3 mm inﬁltrated leaf fragments were ﬁxed
overnight in 2.5% gluteraldehyde (25% gluteraldehyde diluted in
0.1 M phosphate buffer [20 mM sodium dihydrogen(ortho)phos-
phate (NaH2PO4) and 80 mM disodium hydrogen(ortho)phosphate
(Na2HPO4), pH 7.4]) at 4 C. The following day the leaf fragments
were washed 3 times, 5 min for each wash, in 0.1 M phosphate
buffer (pH 7.4). The leaf fragments were ﬁxed for 1 h in one part 2%
osmium tetroxide and one part 0.2 M phosphate buffer (40 mM
NaH2PO4 and 160 mM Na2HPO4, pH 7.4), followed by washing
twice for 5 min with 0.1 M phosphate buffer and two washes of
5 min each with sterile water.
After washing, the leaf fragments were sequentially dehydrated
by incubating for 5 min each in 30%, 50%, 70%, 80%, 90% and 95%
ethanol. The fragments were incubated for 10 min in 100% ethanol;
this step was repeated twice. Finally, the leaf fragments were further
dehydrated by 10 min incubation in 100% acetone, repeated twice.
The leaf fragments were mixed O/N in 1:1 acetone: Spurr’s (Agar
Scientiﬁc) resin. The following day half of the 1:1 acetone: Spurr’s
resin mixture was removed and replaced with 100% Spurr’s resin to
yield a 1:3 acetone: Spurr’s resin mixture. The samples were mixed
for 4 h at room temperature, after which the acetone/resin mixture
was removed and replaced with 100% Spurr’s resin. The leaf
fragments were incubated in 100% Spurr’s resin for three days at
4 C. The 100% Spurr’s resin was replaced with fresh resin and
incubated for 4 h at room temperature after which the resin was
replaced again and incubated overnight at room temperature. The
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and baked for 24 h at 60 C.
The embedded leaf specimens were cut into ultrathin sections
with a diamond knife and collected onto copper grids (mesh size
200). The copper grids were stained with 2% uranyl acetate for
10 min after which they were rinsed with water. Thereafter, the
grids were blotted dry and transferred to lead citrate for 10 min
after which the grids were washed with water and blotted dry.
Grids were viewed using a Technai G2 TEM.
3. Results and discussion
3.1. Expression of BTV-8 capsid proteins in N. benthamiana
Each set of 4 recombinant constructs (listed in Table 1) was
initially co-inﬁltrated into N. benthamiana leaves using a syringe
with a relative vector concentration ratio of 1:1:1:1 (VP2:VP3:VP5:
VP7), at a ﬁnal OD600 value of 0.25 for each construct. Preliminary
screening of pEAQ-HT inﬁltrated leaf tissue after 1, 3, 5 and 7 days
post inﬁltration (dpi) using western blot analysis showed thatFig. 1. Western blot analysis of crude N. benthamiana extracts to detect BTV-8 capsid prot
7 days using 3 different vectors: (a) pEAQ-HT, (b) pTRAc-HT, (c) pTRAkc-AH and (d) pTRAk
each individual construct (with an OD600 = 1.0 for VP5), using an inﬁltration ratio of 1:1:2
lane. In all cases PageRulerTM Prestained Protein Ladder (Thermo Scientiﬁc) was used as a 
inﬁltration medium.although VP2, 3 and 7 were present in crude extracts, VP5 did not
co-express (results not shown).
It has been shown that an increase in the density of
Agrobacterium cells inﬁltrated into lettuce played an important
role in increasing transgene expression and expressed protein
levels [43]. To determine whether an increase in cell density would
inﬂuence BTV-8 VP expression using the pTRA and pEAQ-HT sets of
constructs, inﬁltration of N. benthamiana using different OD600
values of the recombinant Agrobacterium constructs was tested.
The concentration of the recombinant Agrobacterium constructs
encoding VP5 was subsequently doubled to an OD600 of 0.5 (for
both pTRA and pEAQ-HT constructs) and inﬁltration carried out at a
concentration ratio of 1:1:2:1 (VP2:VP3:VP5:VP7). Co-inﬁltration
with the pEAQ-HT constructs resulted in expression of all 4 capsid
proteins at 5 and 7 dpi. Only expression of VP3 and VP7 was
detected during the time-trial using the pTRAc-HT and pTRAkc-
rbcs1-cTP vectors, whereas co-inﬁltration with the pTRAkc-AH
constructs resulted in expression of VP5 and VP7 (data not shown).
The cell concentrations used for co-inﬁltration was further
increased to OD600 = 0.5 for constructs expressing VP2, VP3 andein co-expression. BTV-8 capsid protein co-expression (VP2, VP3, VP5 and VP7) over
c-rbcs1-cTP. Each set of recombinant constructs was co-inﬁltrated at OD600 of 0.5 for
:1 (VP2:VP3:VP5:VP7). Equal amounts (120 mg) of total protein were loaded in each
size marker and the negative control was crude leaf extract of a plant inﬁltrated with
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further increased to OD600 = 1.0. Successful co-expression of all
4 recombinant proteins using the pEAQ-HT plant expression vector
was detected at 5 and 7 dpi (Fig. 1a). Expected band sizes of
111 kDa, 102 kDa, 59 kDa and 38 kDa corresponding to VP2, 3, 5 and
7 respectively, were visualized with the most protein detected at
7 dpi.
Using the pTRAc-HT plant expression vector, accumulation of
VP2, VP3 and VP7 was detected at 3 and 5 dpi (Fig. 1b); after 7 dpi
VP2 was not detected. Co-expression with the pTRAkc-AH
constructs, resulted in expression of VP7 from 1 to 7 dpi, with
VP2 and VP3 visible from 3 dpi onwards (Fig. 1c). The pTRAkc-
rbcs1-cTP set of constructs resulted in the expression of VP2,
VP3 and VP7 from 1 to 7 dpi (Fig. 1d). Noticeably, expression of
VP5 was not detected in any crude extracts sampled from 1 to 7 dpi
for the pTRA plant expression vectors (Fig. 1b–d). In addition, there
was a difference between the different ratios of expressed VP
proteins (particularly VP3 and VP7) using the two different
systems.
The lack of detection of VP5 expression using the pTRA suite of
vectors could be due to the fact that this protein is generally
expressed at low levels due to its inherent nature, and that the
HyperTrans (CPMV-HT) transcription system expresses proteins at
signiﬁcantly higher levels than the p35SS promoters of the pTRA
vectors; thus in the case of VP5, this protein is expressed by the
pEAQ-HT vector at a level which it is detectable by western blot and
not when using the pTRA vectors.Fig. 2. Western blot analysis of crude N. benthamiana extracts. BTV-8 capsid protein co-e
VP5:VP7 ratios of (a) 1:1:2:1, (b) 2:1:1:1 and (c) 1.5:1:1:6.5. A starting cell concentration o
was adjusted according to the ratios used. PageRulerTM Prestained Protein Ladder (Thermo
of a plant inﬁltrated with inﬁltration medium.For comparison of the pTRA suite of vectors themselves, it is
important to recognize that the resultant VP products using the
pTRAc-HT constructs had a 6 his tag on the C-terminus and it is
possible that this may have indirectly inﬂuenced VP5 longevity in
the plant host cell: it has been shown that VP5 interacts strongly
with VP7 and assembly of VP5 precedes that of VP2 in the making
of VLPs [24]. It is possible that in the use of the pTRAc-HT
constructs, CLPs (consisting of VP3 and VP7) may not have
assembled correctly due to the presence of the 6 his tags and that
although VP5 was expressed, it was degraded by plant host
proteases due to the absence of CLP scaffolds for it to interact with
and therefore was not detectable on the western blots. This may be
substantiated by our observation in a different experiment for
which results are not shown, where although pEAQ-HT constructs
encoding C-terminal his-tagged VP3 and VP7 yielded proteins
which were detectable by western blot, no CLP assembly was
determined by transmission electron microscopy (TEM). In the
case of apoplast or chloroplast-targeted BTV VPs (directed by
pTRAkc-AH and pTRAkc-rbcs1-cTP expression vectors, respective-
ly), the assembly of the CLPs or VLPs will likely take place in these
particular organelles, after expression of the individual VPs which
have N terminal signal sequences directing them either to the
chloroplast or apoplast. In these cases, similarly to cytoplasm-
targeted protein, VP5 may be degraded due to the lack of CLP
scaffolding available. In addition, the cytoplasm of both animal and
plant cells has a pH of 7.0–7.5, whereas the apoplast and
chloroplast have pH values of 5.8 and 8.0, respectively [12,36].xpression (VP2, VP3, VP5 and VP7) using pEAQ-HT constructs inﬁltrated at VP2:VP3:
f OD600 = 0.5 for each recombinant construct was maintained and the concentration
 Scientiﬁc) was used as a size marker and the negative control was crude leaf extract
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VLPs in the appropriate organelles, thus further abrogating the
stabilisation of VP5 via particle formation and thus leading to its
degradation.
There may be several reasons for the observation of the
difference in VP3:VP7 ratios between the pEAQ-HT and pTRA suite
of vectors. One explanation could be the fundamental difference in
gene size: the VP3 protein is much larger than VP7 and therefore if
both proteins are expressed at the same rate, there will be more
VP7 than VP3. Possibly the difference could be explained by a
variable effect of the HT regulatory sequences (in the pEAQ-HT
vector) on genes of different lengths (VP3 and VP7 are approxi-
mately 2.7 kb and 1 kb, respectively). It is not likely the difference is
attributed to the 6 his tag, as although it is known that the
presence of terminally fused 6 his tags can inﬂuence protein
expression, in this case only the pTRAc-HT constructs (and not
pTRAKc-AH nor pTRAkc-rbcs1-cTP constructs) result in recombi-
nant proteins with 6 his tags.
There is a small chance that the difference in expression levels
observed between the pTRA vector suite and the pEAQ-HT vector
could be attributed to the presence of the P19 silencing suppressor
which is integrated into the T-DNA of the pEAQ-HT vector. This
ensures that both the gene of interest and the silencing suppressor
are transferred to the same plant host cells, thereby ensuring
concomitant suppression of post transcriptional gene silencing
activity and expression of recombinant protein [32]. In the case of
the pTRA vectors, Agrobacterium cells hosting the silencing
suppressor plasmid (pBIN-NSs) – P19 was not available in the
laboratory in a separate plasmid at the time – were co-inﬁltratedFig. 3. TEM analysis of crude extracts. Transmission electron micrographs of leaves i
recombinant pEAQ-HT plasmids at 6 dpi—(a) 1:1:2:1, (ii) 2:1:1:1, (b) 1.5:1:1:6.5. (c) A ne
also viewed. The crude extracts were captured onto copper grids with anti-BTV sheep s
bars: (a–c) 50 nm and (d) 200 nm.with the plant expression vectors containing the genes of interest.
Co-inﬁltration does not necessarily guarantee that both the
silencing suppressor plasmid and the recombinant plasmid with
the gene of interest are taken up and expressed by the same plant
cells. The use of two different silencing suppressors could also have
inﬂuenced expression levels as they inﬂuence the suppression
process differently. P19 binds siRNA and miRNA non-speciﬁcally,
resulting in a reduced amount of free siRNA duplexes and the
silencing response is reduced by P19 interfering with siRNA
loading of the RNA-induced silencing complex [15]. On the other
hand, NSs interferes with siRNA synthesis by preventing long
dsRNA from being processed into siRNA by dicer-like proteins [34].
Further increasing the cell concentrations above an OD600 of
1.0 resulted in necrosis of the inﬁltrated N. benthamiana leaves and
did not enhance co-expression of the capsid proteins. It is possible
that the higher concentration of Agrobacterium cells may have been
detrimental to normal plant regulatory functions [43], causing the
plant cells to die off which results in abrogation of heterologous
protein expression.
Further work could include calculations of the molar ratio of all
four proteins in order to help ﬁnd a better inﬁltration ratio.
However, since the pEAQ-HT set of constructs showed the highest
co-expression levels of all 4 VPs by qualitative comparison, further
optimization experiments were carried out using only this set of
constructs. The harvest time post inﬁltration was extended to 9 dpi
in order to determine whether protein levels perhaps increased
beyond 7 dpi. The most intense bands for all 4 proteins were
observed at 7 and 8 dpi, with recombinant protein levels showing a
slight decrease after 8 dpi (Fig. 2a).nﬁltrated with the three different ratios tested of A. tumefaciens harbouring the
gative control crude extract of a plant inﬁltrated with inﬁltration medium only was
erum and viewed using a Technai G2 transmission electron microscope (FEI). Scale
Fig. 4. Western blot analysis of density gradient fractions. Fractions 1–8 from 30 to
60% iodixanol gradient centrifugation of pEAQ-HT VLPs probed with anti-BTV-8
antiserum. PageRulerTM Prestained Protein Ladder (Thermo Scientiﬁc) was used as a
size marker.
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recombinant pEAQ-HT Agrobacterium constructs were also tested
in order to ﬁnd an optimal co-expression approach for the 4 VPs. In
addition to the ratio of 1:1:2:1 used above, the ratios of 2:1:1:1 and
1.5:1:1:6.5 (VP2:VP3:VP5:VP7) were tested. The 2:1:1:1 ratio was
chosen as VP2 is the largest protein and the ratio of 1.5:1:1:6.5 cor-
related to the ratio of the number of copies of each of the VPs on the
BTV virion as determined by cryo-electron microscopy [11,27,29].
Co-inﬁltration of the recombinant pEAQ-HT constructs in a ratio of
2:1:1:1 resulted in the presence of VP2 (111 kDa), VP3 (102 kDa)
and VP7 (38 kDa) on the western blot at 6 dpi with no VP5 visible
(Fig. 2b). At 7 and 8 dpi, all 4 VPs constituting the VLPs were
observed, with VP5 becoming less visible after 9 dpi. In
comparison, inﬁltration at a cell density ratio of 1.5:1:1:6.5
(Fig. 2c) resulted in co-expression of all 4 capsid proteins at 6 dpi,
with VP5 at barely detectable levels. From 7 to 9 dpi only VP2,
VP3 and VP7 could be detected on the western blot. In summary,
from these qualitative western blots, the use of the inﬁltration ratio
of 2:1:1:1 and harvesting of leaves at 7 and 8 dpi showed that all
4 VP proteins were expressed at similar levels.
3.2. Electron microscopy of crude leaf extracts
TEM was carried out on crude leaf extracts of the 6–9 dpi pEAQ-
HT samples that were inﬁltrated using the relative vector
concentration ratios of 1:1:2:1, 2:1:1:1 and 1.5:1:1:6.5 to assess
whether co-inﬁltration resulted in the assembly of intact core-like
particles (CLPs) or virus-like particles (VLPs). It was expected that
they could be distinguished from each other by a difference in size,
with VLPs having diameters ranging in size from 72 to 80 nm and
CLPs ranging in diameter from 60 to 69 nm. The formation of both
CLPs and VLPs (Fig. 3) were conﬁrmed in samples harvested at all
3 time points (6, 7 and 8 dpi) tested. Although CLPs were seen in
crude extracts from N. benthamiana inﬁltrated with all 3 ratios
tested (Fig. 3), there were no VLPs visible in samples from N.
benthamiana leaves which were co-inﬁltrated using the ratios of
both 2:1:1:1 and 1.5:1:1:6.5 (VP2:VP3:VP5:VP7, Fig. 3b and c). The
western blot (Fig. 2) and EM results (Fig. 3) indicated the
importance of VP5 in the assembly of VLPs; it appeared that
VP5 was not as readily expressed as the other VPs. Therefore,
increasing the inﬁltration volume of the recombinant Agro-
bacterium carrying VP5, increased the amount of VP5 being
successfully co-expressed with the other VPs.
3.3. Puriﬁcation of putative BTV-8 VLPs
Since VLPs were observed in crude leaf extracts from samples
inﬁltrated with pEAQ-HT constructs in the ratio of 1:1:2:1, the
number of plants inﬁltrated with this particular construct was
scaled up to produce larger amounts of VLPs for puriﬁcation using
density gradient centrifugation. In addition, several small mod-
iﬁcations were made to the method of puriﬁcation to promote VLP
stability: plant tissue was not ground up in liquid nitrogen but
homogenized in buffer, and the extraction buffer containing bicine
(similar to that used by Theuenemann et al. [37] did not include
DTT or NLS; DTT is a redox reagent that reduces disulphide bridges
of proteins and prevents intra-molecular disulphide bonds from
forming between cysteine residues, while NLS is a detergent that
denatures proteins by reducing solvent-inaccessible disulﬁde
bonds. The inﬁltrated plant tissue was harvested at 9 dpi, as this
was found to be the day at which the most intact VLPs could be
puriﬁed by ultracentrifugation, as determined by TEM analysis.
Furthermore, the best ratio for all 4 VPs were also detected at 9 dpi
with western blot analysis (Fig. 2a). The puriﬁed fractions were
separated on an 8% SDS polyacrylamide gel.Western blot analysis of the ﬁrst 8 fractions collected from the
iodixanol gradient after centrifugation showed the presence of all
four bands constituting the BTV-8 VLPs (VP2, 3, 5 and 7) in
fractions 4 (approximately 40–50% iodixanol) to 8 (20–30%
iodixanol, Fig. 4). These samples were also resolved on a
Coomassie-stained SDS-polyacrylamide gel (not shown): only
VP3, VP5 and VP7 were observed on the gel.
3.4. Electron microscopy of density gradient-puriﬁed VLP fractions
TEM of fraction 4 from the density gradient showed a mixed
population of subcore-like particles, CLPs and VLPs based on
diameter measurements (Fig. 5a and b). Subcore-like particles had
a diameter of 52–54 nm and were hexagonal, angular or round,
depending on their orientation on the grid. CLPs measured 60–
69 nm in diameter and VLPs measured 72–80 nm in diameter. Ten
ﬁelds of view, at a magniﬁcation of 14,500 showed approximately
80 particles in each view, of which approximately 10% were VLPs
(Fig. 5a, one ﬁeld of view shown). Fig. 5b shows more detail of the
particles, at 50,000 magniﬁcation, making it easier to distinguish
CLPs (single shelled particles–white arrow) from VLPs (double
shelled particles–black arrows). Although all 4 VP proteins were
detected in fractions 5–8 by western blot (Fig. 4), only CLPs were
observed by TEM analysis of these samples (results not shown).
Since VLPs are comprised of all 4 VPs, they are more dense and
therefore will be found at the lower end of the gradient which may
explain their absence in the higher fractions 5–8. These results
indicate that although VP2 and VP5 are co-puriﬁed in the gradient
with CLPs, the VLPs may not be stable during puriﬁcation where
VP2 and VP5 dissociate from the scaffolding surface provided by
the CLPs. Thus, even though the proteins are detected on western
blots they are not incorporated into fully formed particles. These
results indicated that puriﬁcation of VLPs needs to be further
optimized to separate VLPs from CLPs (Fig. 5a and b). This could be
achieved by changing the iodixanol gradient range or varying the
gradient slope to separate the two particle types further.
3.5. In situ TEM of BTV-8 capsids
Leaves inﬁltrated with recombinant pEAQ-HT A. tumefaciens
constructs using a relative vector concentration ratio of 1:1:2:1
(VP2:VP3:VP5:VP7) were harvested at 9 dpi, embedded in Spurr’s
resin and subsequently viewed using TEM. It was conﬁrmed with
western blot analysis that all four capsid proteins were successfully
expressed at 9 dpi (results not shown).
Fig. 5. TEM analysis of fraction 4 taken from 30 to 60% iodixanol gradient. (a) 14,500 magniﬁcation of BTV8 VLPs and CLPs ranging in size from 70 to 88 nm in diameter. (b) A
50,000 magniﬁcation of the same view. Black arrows indicate VLPs measuring 80 nm in size, the white arrow shows a CLP of 65 nm and the empty white arrow indicates a
subcore-like particle (measuring 53 nm). Scale bars: (a) 500 nm and (b) 200 nm. The images were obtained using a Technai G2 transmission electron microscope.
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observed in the cytoplasm of the plant cells where particles were
accumulated (Fig. 6). The particles ranged from 61 to 83 nm in
diameter, indicating the existence of a mixed population of
particles consisting of both CLPs and VLPs. Fig. 5a and b shows the
same ﬁeld of view at 5700 and 17,000 magniﬁcation,Fig. 6. TEM analysis of leaf sections that were inﬁltrated with recombinant pEAQ-HT pla
one ﬁeld of view at 5700 and 17,000 magniﬁcation, respectively. (c) Negative contro
0.5 mm, (b) and (c): 0.2 mm. CW: cell wall, CPT: chloroplast, CYT: cytoplasm.respectively. CLPs and VLPs did not accumulate in every plant
cell (results not shown), but when a cell did contain particles, there
were more than 2000 particles per ﬁeld of view (Fig. 6a). No similar
structures were observed in the negative control samples
inﬁltrated with inﬁltration media (Fig. 6c). French and Roy [8]
showed that insect cell-produced CLPs also aggregated assmids using an inﬁltration ratio of 1:1:2:1 (VP2:VP3:VP5:VP7). (a) and (b) represent
l leaf inﬁltrated with inﬁltration medium at 17,000 magniﬁcation. Scale bars (a):
A.R. van Zyl et al. / Biotechnology Reports 9 (2016) 15–24 23paracrystalline arrays within the cytoplasm. BTV virions assemble
within the cytoplasm of infected host cells, whereafter they are
released from the cells in a process mediated by the non-structural
BTV protein, NS3 [1,23]. The in situ results from this study together
with the work done by French and Roy [8] suggest that
recombinantly-produced CLPs and VLPs assemble within the
cytoplasm, similar to native BTV virions. The absence of
NS3 from recombinantly-produced particles possibly results in
their retention within the plant cell cytoplasm.
4. Conclusions
In recent years, plants have become an increasingly popular
vehicle for expressing recombinant proteins [30,31]. They have
many advantages, including the ease of scale up, lower cost of
production compared to that in mammalian or insect cells, their
ability to carry out post translational modiﬁcations such as
glycosylation, as well as providing the opportunity to target
protein expression to different subcellular locations and thereby
increase stability and accumulation. They have an added advantage
for the production of veterinary vaccines in particular, since
regulatory bodies still allow animals to be dosed with crude plant
extracts or preparations with limited processing for medicinal
purposes, whereas regulations regarding dosing of medicines to
humans are far more stringent [17]. Since the downstream cost of
making plant-produced proteins ranges from 65 to 95% of the total
cost of manufacture [42], the requirement for less stringent purity
of products contributes even further in favour of making veterinary
vaccines in plants.
The expression of subunit vaccines in plants for several different
animal viral diseases, including avian inﬂuenza, Foot-and-mouth
disease and Newcastle disease has previously been reported [17].
Virus-like particles are particularly appealing for veterinary
vaccines as they stimulate strong humoral and cellular immune
responses and have potential for use as vectors to present
multimeric epitopes against different strains of the same viruses
[4]. While the successful plant production of BTV-8 VLPs has been
reported elsewhere [37], this study – performed simultaneously –
was aimed at comparing the ability of several different plant
expression vectors to transiently co-express the 4 capsid proteins
of BTV-8 (VP2, VP3, VP5 and VP7) in N. benthamiana leaves, and to
form intact VLPs which could potentially be used as a vaccine. This
is the ﬁrst time that recombinant BTV VLPs have been shown to
aggregate in paracrystalline arrays in the cytoplasm of plant cells
when transiently expressed.
The approach used here to produce BTV VLPs in plants contrasts
to that of Thuenemann et al. [37], in that it is more ﬂexible in terms
of being able to vary individual Agrobacterium construct densities
for “tuning” protein expression. This approach may be necessary
for making vaccines for BTV serotypes other than BTV-8, as there is
no guarantee that the individual VPs of these will be expressed in
the same ratios as has been shown for BTV-8.
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